Signifier Medical Technologies LLC has reportedly announced that CMS (Centers for Medicare & Medicaid Services) has set two new Level II HCPCS (Healthcare Common Procedure Coding System) codes. These codes represent eXcite^OSA, the first FDA-approved de-novo device for daytime treatment of primary snoring and mild OSA (obstructive sleep apnea).

Akhil Tripathi, Signifier’s Chief Executive Officer, stated that the company is witnessing strong demand for the eXcite^OSA therapy with more than 3,000 patients treated with this therapy.

Setting codes showcases a crucial achievement for health systems, physicians, payers, DME suppliers, and patients. It will allow the company to further demonstrate the real-world advantages of enhanced outcomes, substantially enhanced quality of care, and cost savings for patients. Reimbursement will aid patients in the United States diagnosed with sleep disordered breathing with an alternative to attain a new, efficient daytime treatment.

According to Dr. Marc Benton, a sleep medicine specialist and a pulmonologist based in New Jersey, eXcite^OSA is an easy-to-use, non-invasive therapy that does not need patients to wear any device while sleeping. With the establishment of reimbursements, it will be easier to access eXcite^OSA for a wider and diverse patient population diagnosed with sleep apnea.

For the record, Signifier is a leading provider of sleep disordered solutions. The company is focused on the production and promotion of inventive, non-invasive solutions for patients with conditions like primary snoring and Obstructive Sleep Apnea.

The Boston-based company leads the sleep therapy sector, with an aim to develop therapies that enhance population health, generate healthcare savings, and increase the quality of patient experiences.

eXcite^OSA is a transformative daytime therapy device developed for treating sleep disordered breathing. It is clinically proven to focus on a common primary cause of OSA and it enhances sleep quality, health, as well as quality of life.

Source credit:

https://www.businesswire.com/news/home/20220222005659/en/Signifier-Medical-Technologies-is-Granted-HCPCS-Codes-for-eXciteOSA-to-Help-Patients-Access-Innovative-Technology